🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Wendell Berry sums up our current health predicament perfectly... “People are fed by the food industry, which pays no attention to health, and are treated by the health industry, which pays no attention to food.”

#CNICPhDay2022 is a fantastic opportunity for early career investigators for broadening their horizons and expanding their network. Don't miss out this opportunity! More information 👇👇 SEBBM Soc Biofísica España Academia Joven de España

Today, we gathered for the last time before Friday to get everything sorted out for Friday #CNICPhDay22 🥳 CODE: KEEPPIPETTING

All the new papers that I need to read

Nos hace mucha ilusión poder explicar que es el ADN y como sus mutaciones nos afectan en forma de juegos #NocheEuropeadelosInvestigadores Madri+d Instituto de Salud Carlos III (ISCIII) Enrique Lara-Pezzi SOMM alliance Ministerio de Ciencia, Innovación y Universidades

#esgct2023 just started! but first some basic knowledge of belgian beers & waffles ✨

Very inspired after listening to #esgct2023 presidential symposium given by David R. Liu The future for genetic diseases looks brighter than ever!

After a 2.5 hours poster session yesterday and 2 hours today, this is still the mood at #esgct2023 non-stop conversations about great science!

Poster session time at #Embocardiobiology

Amazing start to #ESGCT2024 in Rome 🇮🇹 to what will be 4 days full of great and interesting science. (Bonus: reminder about Italian food etiquette ✨ by Dr. Auricchio).

In the session from 09:00 to 11:00 at Meeting Room 2, Laura Lalaguna (CNIC) will explain "AAV delivery of wild type TMEM43 as a novel therapeutic approach for arrhythmogenic right ventricular cardiomyopathy type 5." Don’t miss it! 🫀 #ESGCT2024

Title: Nuclear Love Affair. TMEM43 staining in HL1 cells. Credits: Laura Lalaguna Díaz.

💡🫀 La memoria del corazón: una lesión cardíaca puede afectar a la siguiente generación. ➡️ Investigadores del CNIC y la Universidad de Berna descubren que una #cirugía cardíaca en la infancia puede dejar una “memoria” que influye en la salud del corazón de la

🧪 Una innovadora #TerapiaGénica podría transformar el tratamiento de la #miocardiopatía arritmogénica tipo 5 (ARVC5), una enfermedad genética cardiaca rara y letal. ❤️‍🩹🧬 Investigadores del CNIC, liderados por Enrique Lara-Pezzi, demuestran que introducir una versión sana del

#Cardiología | ➡️ Una innovadora #terapia génica, desarrollada en el CNIC, podría transformar el tratamiento de la #miocardiopatía arritmogénica tipo 5 (ARVC5). 📄Publicada en Circulation Research. diariomedico.com/medicina/cardi…

.CNIC Breakthrough gene therapy offers hope for rare, deadly heart disease in young men biotech-spain.com/en/articles/br…

Laura Lalaguna shows that overexpressing #TMEM43 in #ARVC5 mice enhances heart function, prevents #arrhythmias, & extends lifespan. Find out more about AAV-based gene therapy to treat ARVC5 at ahajrnls.org/3GnIgfK Enrique Lara-Pezzi Pablo Garcia-Pavia

Breaking News: A baby with a rare disorder made medical history by receiving the first custom gene-editing treatment. The technique used has the potential to help people with thousands of other uncommon genetic diseases. nyti.ms/4j3xGs8

In a medical milestone, a customized base editor was developed, characterized in human and mouse cells, tested in mice, studied for safety in non-human primates, cleared by U.S. FDA for clinical trial use, manufactured as a complex with an LNP, and dosed into a baby with a severe,

Incredible story that we learned about today at #ASGCT2025!